More about Pyruvate Dehydrogenase Complex Deficiency
When the complex fails, pyruvate is turned into lactic acid instead. Lactic acid builds up in the blood and brain, and the brain, which needs a constant energy supply, takes the most damage.
Keep reading about Pyruvate Dehydrogenase Complex Deficiency
Most cases come from the PDHA1 gene on the X chromosome, and many of these are new changes that neither parent carries. Changes in PDHX, PDHB, DLD, DLAT or PDP1 cause the rest and are inherited in an autosomal recessive pattern, from both parents.
There is no FDA-approved drug for PDCD as of October 2026. The ketogenic diet, very high in fat and low in carbohydrates, is the standard treatment because it gives the brain fuel that bypasses the broken step. High-dose thiamine (vitamin B1) helps a minority of people, most often those with certain PDHA1 changes, so doctors usually try it. Care involves a metabolic specialist, a dietitian experienced with the ketogenic diet and a neurologist.
What are the symptoms of Pyruvate Dehydrogenase Complex Deficiency?
These are common symptoms of Pyruvate Dehydrogenase Complex Deficiency, and how strong they are varies from person to person.
- Lactic acid buildup, which can cause vomiting, fast breathing and an abnormal heartbeat
- Weak, floppy muscles in infancy
- Developmental delay
- Seizures
- Poor coordination or trouble walking
- A small head size
Who gets Pyruvate Dehydrogenase Complex Deficiency?
Symptoms usually start soon after birth, though onset ranges from before birth to later childhood; in one review the median age at diagnosis was about 20 months. Most cases, 76-85%, come from the PDHA1 gene on the X chromosome. Boys with a PDHA1 change are affected, while girls range from no symptoms to as severe as boys, depending on which X chromosome is active in their cells, so boys and girls are diagnosed about equally often.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Which new Pyruvate Dehydrogenase Complex Deficiency medicines are in trials?
Investigational medicines Trial Friend tracks for Pyruvate Dehydrogenase Complex Deficiency, with trial results, safety findings and where each one stands.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Pyruvate Dehydrogenase Complex Deficiency
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Pyruvate Dehydrogenase Complex Deficiency resources
Reputable organizations and medical references for learning more about Pyruvate Dehydrogenase Complex Deficiency, including disease registries, foundation resources, and clinical guidelines.
- GeneReviews - Primary Pyruvate Dehydrogenase Complex Deficiency Overview
- MedlinePlus Genetics - Pyruvate Dehydrogenase Deficiency
- Saol Therapeutics - FDA accepts SL1009 resubmission with a December 30, 2026 PDUFA date
- NeurologyLive - FDA accepts SL1009 resubmission for PDCD
- Kaufmann et al., Dichloroacetate causes toxic neuropathy in MELAS, Neurology 2006
- Saol Therapeutics - Submission of NDA for SL1009 (December 3, 2024)